HomeScienceRAB Proteins Drive Lumen Formation in
SCIENCE

RAB Proteins Drive Lumen Formation in Human Epiblast Model

Researchers found that RAB35 and RAB7 regulate endo-lysosomal remodeling required for lumen formation during human epiblast development.

WHAT YOU NEED TO KNOW
  • RAB35 and RAB7 GTPases are required for apicosome formation and lumen morphology in the epiblast model.
  • Apicosome development triggers a transient expansion of early endosomes, late endosomes, and lysosomes.
  • The research was supported by NIH grants R01-HD098231, R01-HD102496, and R01-GM129255.
  • Nature Communications received the paper on August 18, 2025, accepted it on August 17, 2026, and published it on August 27, 2026.

Researchers demonstrated that internal cellular transport pathways direct cavity development in human embryonic models, according to a peer-reviewed study published in Nature Communications. The work centers on epiblast lumen formation, a structural step during human embryo implantation that begins with an apical compartment called an apicosome. Material for the apicosome comes partly from endocytosis.

Tests using human pluripotent stem cell-derived models showed that apicosome generation prompts a temporary expansion across multiple stages of the endo-lysosomal pathway. Early endosomes, late endosomes, and lysosomes all enlarge transiently during this transition. In addition, the cells assemble hybrid compartments that combine physical features from both early and late endo-lysosomal phases.

Two regulatory proteins govern these membrane shifts. The researchers found that the RAB GTPases RAB35 and RAB7 are required for proper apicosome formation and lumen morphology. Membrane remodeling dependent on these two GTPases serves as a primary mechanism driving apical membrane morphogenesis in the human epiblast model.

Scientists from the Medical College of Wisconsin and the University of Michigan Medical School conducted the study. The team sourced experimental vectors and constructs from researchers at Kyoto University, McGill University, and Rockefeller University, while using the University of Michigan Proteomics Resource Facility during the project.

National Institutes of Health grants R01-HD098231, R01-HD102496, and R01-GM129255 funded the research alongside Medical College of Wisconsin start-up funds. Nature Communications accepted the paper on August 17, 2026, following submission on August 18, 2025, and published it on August 27, 2026.

Xentir Media
Xentir Media NewsroomSource-backed AI and technology coverage, drafted by Xentir's automated editorial system under fixed human-set rules. See our editorial policy and AI usage policy.
J
Jomon · Founder & EditorFounder and editor of Xentir Media. Sets the editorial rules the newsroom system runs under, and is accountable for its corrections. About Jomon · [email protected]
The Xentir Brief
The developments worth knowing — one useful email.
Get the Brief →